40 participants
Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-09-25
- Start Date:
- 2025-09-19
- Completion:
- 2029-09-30
Conditions
- Localized Colon Carcinoma
- Stage IIB Colon Cancer AJCC v8
- Stage IIC Colon Cancer AJCC v8
- Stage III Colon Cancer AJCC v8
Interventions
- PROCEDURE
- OTHER
- DRUG
No Results Yet